BCM
VRTX icon

Barometer Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Barometer Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,827
Closed -$3.86M – 236
2024
Q1 		$3.86M Buy
9,827
+340
+4% +$144K 1% 34
2023
Q4 		$3.86M Sell
9,487
-3,342
-26% -$1.23M 1.09% 28
2023
Q3 		$4.46M Buy
12,829
+2
+0% +$699 1.41% 25
2023
Q2 		$4.51M Buy
+12,827
New +$4.32M 1.21% 28
2023
Q1 		– Sell
-3,300
Closed -$953K – 166
2022
Q4 		$953K Sell
3,300
-11,757
-78% -$3.58M 0.28% 63
2022
Q3 		$4.36M Sell
15,057
-12,275
-45% -$3.53M 1.8% 19
2022
Q2 		$7.13M Buy
+27,332
New +$7.32M 2.92% 11
2020
Q3 		– Sell
-16,280
Closed -$4.73M – 172
2020
Q2 		$4.73M Buy
16,280
+4,580
+39% +$1.24M 0.88% 47
2020
Q1 		$2.78M Sell
11,700
-2,340
-17% -$537K 0.83% 32
2019
Q4 		$3.07M Buy
+14,040
New +$2.84M 0.49% 54
2019
Q2 		– Sell
-5,300
Closed -$975K – 171
2019
Q1 		$975K Buy
+5,300
New +$979K 0.11% 122
2018
Q2 		– Sell
-98,000
Closed -$16M – 181
2018
Q1 		$16M Buy
+98,000
New +$16M 1.35% 25
2015
Q1 		– Sell
-6,800
Closed -$808K – 170
2014
Q4 		$808K Buy
6,800
+6,157
+958% +$693K 0.07% 85
2014
Q3 		$72K Buy
+643
New +$61.2K 0.01% 116

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Barometer Capital Management's VRTX Position: Q2 2024 in Review

Barometer Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2024, closing a stake of 9,827 shares — an estimated $3.86M sold.

Barometer Capital Management first reported a position in VRTX in Q3 2014 and held it in 14 quarters. The position peaked at $16M in Q1 2018. 1,546 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

  • Barometer Capital Management reported no remaining Vertex Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Barometer Capital Management sold 9,827 Vertex Pharmaceuticals shares in Q2 2024, an estimated $3.86M.
  • Barometer Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2014 and held it in 14 quarters.
  • Barometer Capital Management's Vertex Pharmaceuticals position peaked at $16M in Q1 2018.
  • 1,546 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on Barometer Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.